Acelyrin Inc Stock Ownership - Who owns Acelyrin?

Insider buying vs selling

Have Acelyrin Inc insiders been buying or selling?
Melanie GloriaChief Operating Officer2024-05-1510,298$4.47
Mina KimChief Executive Officer2024-05-1510,230$4.47
Sanam PangaliCLO Head of People2024-05-15921$4.47
Shaolee LinChief Executive Officer2024-04-019,961$6.63
Shaolee LinChief Executive Officer2024-02-2015,701$7.61
Shaolee LinChief Executive Officer2024-01-0210,691$7.41

1 of 1

SLRN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SLRN insiders and whales buy or sell their stock.

SLRN Shareholders

What type of owners hold Acelyrin Inc stock?
Beth C. Seidenberg9.95%9,850,729$50.53MInsider
Westlake Biopartners Fund Ii LP9.89%9,790,729$50.23MInsider
Ayurmaya Capital Management Company LP9.43%9,334,735$47.89MInsider
Ayurmaya Capital Management Company LP9.43%9,334,735$47.89MInstitution
Fmr LLC7.15%7,079,210$36.32MInstitution
Citadel Advisors LLC7.10%7,028,837$36.06MInstitution
Vanguard Group Inc6.30%6,237,543$32.00MInstitution
Blackrock Inc4.84%4,792,730$24.59MInstitution
Millennium Management LLC4.05%4,013,528$20.59MInstitution
Orbimed Advisors LLC4.04%4,001,711$20.53MInstitution

1 of 3

SLRN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SLRN74.37%25.63%Net SellingNet Selling
LXEO70.17%20.83%Net BuyingNet Buying
ADPT61.87%38.13%Net Selling
CRBP41.07%58.93%Net BuyingNet Selling
ITOS59.76%40.24%Net BuyingNet Buying

Acelyrin Stock Ownership FAQ

Who owns Acelyrin?

Acelyrin (NASDAQ: SLRN) is owned by 91.76% institutional shareholders, 31.62% Acelyrin insiders, and 0.00% retail investors. Beth C. Seidenberg is the largest individual Acelyrin shareholder, owning 9.85M shares representing 9.95% of the company. Beth C. Seidenberg's Acelyrin shares are currently valued at $57.43M.

If you're new to stock investing, here's how to buy Acelyrin stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.